Search research articles
Contact Us
Filters
Showing results (61-70 of 220) with videos related to
Page
of 22
Sort By:
Future Medicinal Chemistry
|
June 5, 2019
Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-<i>Trypanosoma brucei</i> agents
George Fytas, Grigoris Zoidis, Martin C Taylor, et al.
Plos Neglected Tropical Diseases
|
July 28, 2020
Non-invasive monitoring of drug action: A new live in vitro assay design for Chagas' disease drug discovery
Anna F Fesser, Olivier Braissant, Francisco Olmo, et al.
European Journal of Medicinal Chemistry
|
September 1, 2010
Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines
Grigoris Zoidis, Nicolas Kolocouris, John M Kelly, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
July 9, 2009
Etching-resistant silver nanoprisms by epitaxial deposition of a protecting layer of gold at the edges
Damian Aherne, Denise E Charles, Margaret E Brennan-Fournet, et al.
Genome Research
|
January 6, 2005
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional "strand-switch" domain as a major feature
Samson O Obado, Martin C Taylor, Shane R Wilkinson, et al.
The Biochemical Journal
|
November 2, 2007
Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite
Lucía Piacenza, Gonzalo Peluffo, María Noel Alvarez, et al.
Plos Neglected Tropical Diseases
|
April 16, 2015
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence
Martin C Taylor, Michael D Lewis, Amanda Fortes Francisco, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2015
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs"
Amanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against <i>T. brucei</i>
Markos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies
George Fytas, Grigoris Zoidis, Antonios Drakopoulos, et al.
Page
of 22
Search research articles
Search
Showing results (61-70 of 220) with videos related to
Sort By:
Page
of 22
Future Medicinal Chemistry
|
June 5, 2019
Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-<i>Trypanosoma brucei</i> agents
George Fytas, Grigoris Zoidis, Martin C Taylor, et al.
Plos Neglected Tropical Diseases
|
July 28, 2020
Non-invasive monitoring of drug action: A new live in vitro assay design for Chagas' disease drug discovery
Anna F Fesser, Olivier Braissant, Francisco Olmo, et al.
European Journal of Medicinal Chemistry
|
September 1, 2010
Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines
Grigoris Zoidis, Nicolas Kolocouris, John M Kelly, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
July 9, 2009
Etching-resistant silver nanoprisms by epitaxial deposition of a protecting layer of gold at the edges
Damian Aherne, Denise E Charles, Margaret E Brennan-Fournet, et al.
Genome Research
|
January 6, 2005
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional "strand-switch" domain as a major feature
Samson O Obado, Martin C Taylor, Shane R Wilkinson, et al.
The Biochemical Journal
|
November 2, 2007
Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite
Lucía Piacenza, Gonzalo Peluffo, María Noel Alvarez, et al.
Plos Neglected Tropical Diseases
|
April 16, 2015
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence
Martin C Taylor, Michael D Lewis, Amanda Fortes Francisco, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2015
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs"
Amanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against <i>T. brucei</i>
Markos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies
George Fytas, Grigoris Zoidis, Antonios Drakopoulos, et al.
Page
of 22